vimarsana.com
Home
Live Updates
தடைசெய்யப்பட்டுள்ளது பயன்பாடு - Breaking News
Pages:
3
4
5
6
7
8
9
Page 2 - தடைசெய்யப்பட்டுள்ளது பயன்பாடு News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Pfizer seeks fast-track approval for vaccine; says it s highly effective against India COVID-19 variant
Pfizer told Indian authorities that its vaccine has demonstrated
United kingdom
South africa
Sri lanka
Sri lankan
Albert bourla
United kingdom public health england
Serum institute
Bharat biotech
Supply agreement
Emergency use authorisation
Restricted use
Post approval commitment
Public health england
Pfizer covid19 vaccine
Pfizer coronavirus vaccine
Covid19 variant in india
Coronavirus News LIVE Updates: Partial Lockdown Extended in Bengal Till June 5; Govt Covid Team Says Will Look into UP Vaccine Mix-up
Coronavirus News LIVE Updates: Partial Lockdown Extended in Bengal Till June 15; Govt Covid Team Says Will Look into UP Vaccine Mix-up News18 1 hour ago News18 © Provided by News18 Coronavirus News LIVE Updates: Partial Lockdown Extended in Bengal Till June 15; Govt Covid Team Says Will Look into UP Vaccine Mix-up Coronavirus News LIVE Updates: Seeking a fast-track approval for its COVID-19 vaccine, US major Pfizer has told Indian authorities that its jab has shown “high effectiveness” against the SARS-CoV-2 variant prevalent in India, while it is suitable for everyone aged 12 years or above and can be stored for a month at 2-8 degrees, sources said on Wednesday. Pfizer, which is ready to offer 5 crore doses to India between July and October this year and has sought certain relaxations including indemnification, has held a series of interactions with the Indian government authorities recently, including one this week, during which it shared the most re
United kingdom
South africa
Sri lanka
Sri lankan
Albert bourla
Govt covid team
United kingdom public health england
Serum institute
World health organisation
Coronavirus news
Partial lockdown extended
Bengal till june
Govt covid team says will look
Bharat biotech
Supply agreement
Emergency use authorisation
Coronavirus News LIVE Updates: Our Vaccine Highly Effective on New Covid Variant, Suitable for 12 Yrs & Above, Pfizer Tells Govt
Coronavirus News LIVE Updates: Pfizer, which is ready to offer 5 crore doses to India between July and October this year, has sought certain relaxations including indemnification.
United kingdom
South africa
Sri lanka
Sri lankan
Albert bourla
United kingdom public health england
Serum institute
World health organisation
Coronavirus news
Vaccine highly effective
New covid variant
Pfizer tells
Pfizer tells govt
Bharat biotech
Supply agreement
Emergency use authorisation
Coronavirus News LIVE Updates: Partial Lockdown Extended in Bengal Till June 15; Govt Covid Team Says Will Look into UP Vaccine Mix-up
Coronavirus News LIVE Updates: Partial Lockdown Extended in Bengal Till June 15; Sputnik V to be Available from 2nd Week of June News18 12 minutes ago News18 © Provided by News18 Coronavirus News LIVE Updates: Partial Lockdown Extended in Bengal Till June 15; Sputnik V to be Available from 2nd Week of June Coronavirus News LIVE Updates: Sputnik V, the third vaccine approved in India, will be available through the Apollo Hospitals from the 2nd week of June. Seeking a fast-track approval for its COVID-19 vaccine, US major Pfizer has told Indian authorities that its jab has shown “high effectiveness” against the SARS-CoV-2 variant prevalent in India, while it is suitable for everyone aged 12 years or above and can be stored for a month at 2-8 degrees, sources said on Wednesday. Pfizer, which is ready to offer 5 crore doses to India between July and October this year and has sought certain relaxations including indemnification, has held a series of interac
United kingdom
South africa
Sri lanka
Sri lankan
Albert bourla
Govt covid team
United kingdom public health england
Serum institute
World health organisation
Coronavirus news
Partial lockdown extended
Bengal till june
Govt covid team says will look
Bharat biotech
Supply agreement
Emergency use authorisation
Govt examining Pfizer s request for indemnity, will take decision on merit: VK Paul
"We are looking at what their expectations are from the government and they are looking at what our expectations are from them," V K Paul said.
Albert bourla
Aayog member health vk paul
Serum institute
World health organisation
Emergency use authorisation
Restricted use
Post approval commitment
Niti aayog
Government of india
ஆயோக் உறுப்பினர் ஆரோக்கியம் வ்க் பால்
சீரம் நிறுவனம்
உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந்
தடைசெய்யப்பட்டுள்ளது பயன்பாடு
நீதி ஆயோக்
அரசு ஆஃப் இந்தியா
vimarsana © 2020. All Rights Reserved.